PF-05089771 / Pfizer  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-05089771 / Pfizer
NCT01529346: Efficacy Of PF-05089771 In Treating Postoperative Dental Pain

Completed
2
235
US
PF-05089771, Placebo, Ibuprofen
Pfizer
Postoperative Dental Pain
06/12
06/12
IEM, NCT01769274: Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia

Completed
2
5
US
PF-05089771, Placebo
Pfizer
Inherited Erythromelalgia
07/13
07/13
NCT02215252: A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Completed
2
141
US
PF-05089771 150 mg, Matched placebo for PF-05089771 150 mg and pregabalin 300 mg, Pregabalin 300 mg, PF-05089771 150 mg + Pregabalin 300 mg
Pfizer
Diabetic Neuropathy, Painful
07/15
09/15

Download Options